1. Home
  2. MRSN vs BEDU Comparison

MRSN vs BEDU Comparison

Compare MRSN & BEDU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRSN
  • BEDU
  • Stock Information
  • Founded
  • MRSN 2001
  • BEDU 1994
  • Country
  • MRSN United States
  • BEDU United Kingdom
  • Employees
  • MRSN N/A
  • BEDU N/A
  • Industry
  • MRSN Biotechnology: Pharmaceutical Preparations
  • BEDU Other Consumer Services
  • Sector
  • MRSN Health Care
  • BEDU Real Estate
  • Exchange
  • MRSN Nasdaq
  • BEDU Nasdaq
  • Market Cap
  • MRSN 40.7M
  • BEDU 47.7M
  • IPO Year
  • MRSN 2017
  • BEDU 2017
  • Fundamental
  • Price
  • MRSN $0.37
  • BEDU $1.81
  • Analyst Decision
  • MRSN Strong Buy
  • BEDU
  • Analyst Count
  • MRSN 5
  • BEDU 0
  • Target Price
  • MRSN $5.75
  • BEDU N/A
  • AVG Volume (30 Days)
  • MRSN 3.1M
  • BEDU 9.6K
  • Earning Date
  • MRSN 05-15-2025
  • BEDU 08-01-2025
  • Dividend Yield
  • MRSN N/A
  • BEDU N/A
  • EPS Growth
  • MRSN N/A
  • BEDU N/A
  • EPS
  • MRSN N/A
  • BEDU N/A
  • Revenue
  • MRSN $34,006,000.00
  • BEDU $224,321,752.00
  • Revenue This Year
  • MRSN N/A
  • BEDU N/A
  • Revenue Next Year
  • MRSN N/A
  • BEDU N/A
  • P/E Ratio
  • MRSN N/A
  • BEDU N/A
  • Revenue Growth
  • MRSN N/A
  • BEDU N/A
  • 52 Week Low
  • MRSN $0.26
  • BEDU $1.35
  • 52 Week High
  • MRSN $2.83
  • BEDU $2.41
  • Technical
  • Relative Strength Index (RSI)
  • MRSN 51.71
  • BEDU 59.65
  • Support Level
  • MRSN $0.33
  • BEDU $1.76
  • Resistance Level
  • MRSN $0.38
  • BEDU $1.81
  • Average True Range (ATR)
  • MRSN 0.04
  • BEDU 0.07
  • MACD
  • MRSN 0.00
  • BEDU 0.02
  • Stochastic Oscillator
  • MRSN 58.60
  • BEDU 80.65

About MRSN Mersana Therapeutics Inc.

Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms include Dolasynthen, which delivers a proprietary auristatin payload, and Immunosynthen, which delivers a proprietary stimulator of interferon genes (STING) agonist payload. Its pipeline includes Emi-Le (XMT-1660), XMT-2056, XMT-2068, and XMT-2175.

About BEDU Bright Scholar Education Holdings Limited each representing four

Bright Scholar Education Holdings Ltd operates as an education service provider. It is engaged in the provision of education services, including complementary education services, operation services for domestic schools, and education programs and services including independent schools and colleges in United Kingdom (the UK) and the United States (the U.S.) Kingdom. It nearly eight overseas school located in the United Kingdom and the United States. It has three reportable segments, including Overseas Schools, Complementary Education Services, and K-12 Operation Services. Key revenue is generated from Overseas Schools. From a geographical perspective: Key revenue is generated from China following UK, U.S., Canada and Singapore.

Share on Social Networks: